Shanghai Pharmaceuticals Holding Co. Ltd. at its EGM held on March 19, 2024, approved election of Mr. YANG Qiuhua as Executive Director of the Eighth Session of the Board for a term until the end of the eighth session of the Board, with effect from 19 March 2024. The Company has received a written resignation letter from Mr. YAO Jiayong, due to work reallocation, Mr. YAO Jiayong ceased to act as a non-executive Director, vice chairman and all other positions held at the Company and its subsidiaries, with effect from 19 March 2024.

At the Board meeting of the Company held on 19 March 2024: Mr. YANG Qiuhua, an executive Director, has been elected by the Board as the chairman of the eighth session of the Board for a term until the end of the eighth session of the Board, with effect from 19 March 2024; Mr. YANG Qiuhua, an executive Director, has been elected by the Board as the convener of the Strategy Committee of the Board; the positions of Mr. CHEN Fashu, a non-executive Director, and Mr. WANG Zhong, an independent non-executive Director, as members of the Strategy Committee of the Board remain unchanged; and Mr. YANG Qiuhua, an executive Director, has been elected by the Board as a member of the Remuneration and Assessment Committee of the Board; the position of Mr. WANG Zhong, an independent non-executive Director, as the convener of the Remuneration and Assessment Committee of the Board; and Mr. GU Zhaoyang, an independent non-executive Director, as members of the Remuneration and Assessment Committee of the Board remain unchanged; Mr. YAO Jiayong, a non-executive Director, ceased to act as a member of the Remuneration and Assessment Committee of the Board.